AXQ Capital’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-45,727
Closed -$110K – 1283
2026
Q2
$110K Buy
45,727
+25,577
+127% +$49.8K 0.01% 826
2026
Q1
$31.4K Buy
+20,150
New +$29.3K ﹤0.01% 952

Other funds holding LXRX

AXQ Capital's LXRX Position: Q3 2026 in Review

AXQ Capital sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2026, closing a stake of 45,727 shares — an estimated $110K sold.

AXQ Capital first reported a position in LXRX in Q1 2026 and held it in 2 quarters. The position peaked at $110K in Q2 2026. 156 funds tracked by Wall St. Rank hold LXRX as of Q3 2026.

  • AXQ Capital reported no remaining Lexicon Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • AXQ Capital sold 45,727 Lexicon Pharmaceuticals shares in Q3 2026, an estimated $110K.
  • AXQ Capital first reported a position in Lexicon Pharmaceuticals in Q1 2026 and held it in 2 quarters.
  • AXQ Capital's Lexicon Pharmaceuticals position peaked at $110K in Q2 2026.
  • 156 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2026.

Based on AXQ Capital's 13F filing for Q3 2026, filed 12 Nov 2026.